Study of possibility of cell recognition in brain tumors. (2020)

Peer-Reviewed Study · Maklygina YS; Skobeltsin AS; Savelieva TA; Pavlova GV; Chekhonin IV; Gurina OI; Chernysheva AA; Cherepanov SA; Loschenov VB · December 23, 2020

Maklygina YS et al., 2020-12-23: Russian brain-tumour study that used methylene blue as an imaging/visualisation agent for microglia and 5-ALA/PpIX for tumour detection – methylene blue was not used here to kill glioblastoma cells.

MB was employed to visualize resident microglia, which is important for their activation/deactivation to prevent the reprogramming of the immune cells by the tumor.

Maklygina YS et al., 2020-12-23: Russian brain-tumour study that used methylene blue as an imaging/visualisation agent for microglia and 5-ALA/PpIX for tumour detection – methylene blue was not used here to kill glioblastoma cells. C3 imaging record. Study type: ex-vivo/in-vivo optical recognition study. Agent: methylene blue as a microglial stain, with 5-ALA-induced PpIX for tumour detection. NO killing endpoint – the study tests cell recognition, not cytotoxicity, so it neither confirms nor refutes the killing claim it is filed under. Study type: lab.